Evidence map›Paper›PMID 36768855›Full record

ArticleInternational journal of molecular sciences2023

The Light-Controlled Release of 2-fluoro-l-fucose, an Inhibitor of the Root Cell Elongation, from a nitrobenzyl-caged Derivative.

Mathieu Carlier, Thomas Poisson, Jean-Claude Mollet, Patrice Lerouge, Cyrille Sabot, Arnaud Lehner

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mathieu CarlierUniversité de Rouen Normandie, GLYCOMEV UR 4358, SFR Normandie Végétal FED 4277, Innovation Chimie Carnot, IRIB, F-76000 Rouen, France.ORCID 0000-0003-0336-1701
Thomas PoissonUniversité de Rouen Normandie, INSA Rouen Normandie, CNRS, COBRA UMR 6014, Innovation Chimie Carnot, F-76000 Rouen, France.ORCID 0000-0002-0503-9620
Jean-Claude MolletUniversité de Rouen Normandie, GLYCOMEV UR 4358, SFR Normandie Végétal FED 4277, Innovation Chimie Carnot, IRIB, F-76000 Rouen, France.ORCID 0000-0001-8717-0034
Patrice LerougeUniversité de Rouen Normandie, GLYCOMEV UR 4358, SFR Normandie Végétal FED 4277, Innovation Chimie Carnot, IRIB, F-76000 Rouen, France.
Cyrille SabotUniversité de Rouen Normandie, INSA Rouen Normandie, CNRS, COBRA UMR 6014, Innovation Chimie Carnot, F-76000 Rouen, France.ORCID 0000-0002-5014-7217
Arnaud LehnerUniversité de Rouen Normandie, GLYCOMEV UR 4358, SFR Normandie Végétal FED 4277, Innovation Chimie Carnot, IRIB, F-76000 Rouen, France.ORCID 0000-0003-4442-1731

Funding

graduate school for research XL-Chem ANR-18-EURE-0020 XL CHEMLabex Synorg ANR-11-LABX-0029Région Normandie projet INFRA
6 · The paper itself

Abstract

Glycan metabolic engineering is a powerful tool for studying the glycosylation in living plant cells. The use of modified monosaccharides such as deoxy or fluorine-containing glycosides has been reported as a powerful pharmacological approach for studying the carbohydrate metabolism. 1,3,4-tri-

Indexed as

FucoseFucosyltransferasesDelayed-Action PreparationsGlycosylationMonosaccharidesDelayed-Action PreparationsFucoseFucosyltransferasesMonosaccharides2-fluoro fucosecaged inhibitorcell wall biosynthesisglycan engineeringglycosyltransferase inhibitorphotoirradiationplant cell elongation

Identifiers

PMID36768855
PMCPMC9916816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.